Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and panto-prazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials - Caro, JJ; Salas, M; Ward, A (Clin Ther., 2001)